Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
|
|
Aprea Therapeutics, Inc. (APRE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Quarterly results |
| 11/09/2022 |
8-K
| Quarterly results |
| 08/11/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 11/08/2021 |
8-K
| Quarterly results|
Docs:
|
"Aprea Therapeutics, Inc. Condensed Consolidated Balance Sheets December 31, 2020 Assets Current assets: Cash and cash equivalents $ 61,428,404 $ 89,017,686 Prepaid expenses and other current assets 750,929 3,399,019 Total current assets 62,179,333 92,416,705 Property and equipment, net 27,318 38,515 Right of use lease and other noncurrent assets 278,209 349,999 Total assets $ 62,484,860 $ 92,805,219 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 2,548,388 $ 4,503,619 Accrued expenses 6,267,429 10,571,237 Lease liability—current 223,999 256,309 Total current liabilities 9,039,816 15,331,165 Lease liability—noncurrent 29,773 78,847 Total liabilities 9,069,589 15,410,012 Commitments and contingencies Stockholders’ equity: Common stock, par value $0.001; 21,360,14..." |
|
| 08/12/2021 |
8-K
| Quarterly results |
| 05/06/2021 |
8-K
| Quarterly results |
| 11/05/2020 |
8-K
| Quarterly results|
Docs:
|
"Aprea Therapeutics, Inc. Condensed Consolidated Balance Sheets September 30, 2020 December 31, 2019 Assets Current assets: Cash and cash equivalents $ 101,146,633 $ 130,088,869 Prepaid expenses and other current assets 1,257,077 2,955,878 Total current assets 102,403,710 133,044,747 Property and equipment, net 40,696 41,639 Right of use lease and other noncurrent assets 389,982 521,499 Total assets $ 102,834,388 $ 133,607,885 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 4,349,977 $ 2,176,852 Accrued expenses 9,084,389 6,642,553 Lease liability—current 244,310 242,329 Total current liabilities 13,678,676 9,061,734 Lease liability—noncurrent 132,773 302,621 Total liabilities 13,811,449 9,364,355 Commitments and contingencies Stockholders’ equity: Common stock,..." |
|
| 08/11/2020 |
8-K
| Quarterly results |
| 05/15/2020 |
8-K
| Quarterly results|
Docs:
|
"Aprea Therapeutics, Inc. Condensed Consolidated Balance Sheets March 31, 2020 December 31, 2019 Assets Current assets: Cash and cash equivalents $ 122,513,357 $ 130,088,869 Prepaid expenses and other current assets 2,090,941 2,955,878 Total current assets 124,604,298 133,044,747 Property and equipment, net 45,934 41,639 Right of use lease and other noncurrent assets 474,898 521,499 Total assets $ 125,125,130 $ 133,607,885 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 3,006,688 $ 2,176,852 Accrued expenses 8,298,769 6,642,553 Lease liability—current 238,771 242,329 Total current liabilities 11,544,228 9,061,734 Lease liability—noncurrent 227,288 302,621 Total liabilities 11,771,516 9,364,355 Commitments and contingencies Stockholders’ equity: Common stock, par..." |
|
| 03/26/2020 |
8-K
| Quarterly results |
| 11/14/2019 |
8-K
| Quarterly results |
|
|